National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 09/10/2009



General Information About Adult Acute Lymphoblastic Leukemia






Stages of Adult Acute Lymphoblastic Leukemia







Recurrent Adult Acute Lymphoblastic Leukemia






Treatment Option Overview






Treatment Options for Adult Acute Lymphoblastic Leukemia






To Learn More About Adult Acute Lymphoblastic Leukemia






Get More Information From NCI






Changes to This Summary (09/10/2009)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Questions about cancer?
1-800-4-CANCER
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to the Nation Finds Continued Declines in Cancer Rates
Recurrent Adult Acute Lymphoblastic Leukemia

Recurrent adult acute lymphoblastic leukemia (ALL) is cancer that has recurred (come back) after going into remission. The ALL may come back in the blood, bone marrow, or other parts of the body.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov